Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

133587 Press Releases
DateTitleCompany
10 Dec 15 Amid Exchange Sustainability Challenges, Softheon Introduces Profit & Loss (P&L) Business Intelligence for Insurance Carriers Softheon,
Published by
PR Newswire
10 Dec 15 Chad Cohen joins Trupanion's Board of Directors Trupanion, Inc.,
Published by
PR Newswire
10 Dec 15 Kamada Completes Enrollment of U.S. Phase 2 Study of Inhaled Alpha-1 Antitrypsin for the Treatment of AAT Deficiency Kamada ,
Published by
PharmiWeb.com
10 Dec 15 Ignyta Receives Orphan Drug Designation in the European Union for Entrectinib for the Treatment of Neuroblastoma Ignyta ,
Published by
PharmiWeb.com
10 Dec 15 Ignyta Appoints William Mccarthy as Chief Business Officer Ignyta ,
Published by
PharmiWeb.com
10 Dec 15 Tonix Pharmaceuticals Completes Enrollment in Phase 2 Clinical Study of TNX-201 in Episodic Tension-Type Headache Tonix Pharmaceuticals ,
Published by
PharmiWeb.com
10 Dec 15 Tonix Pharmaceuticals and U.S. Department of Defense Military Developer in Partnership to Expand Efforts to Examine TNX-102 SL for Post-Traumatic Stress Disorder Tonix Pharmaceuticals ,
Published by
PharmiWeb.com
10 Dec 15 Initiation of fruquintinib Phase III registration trial in non-small cell lung cancer Chi-Med,
Published by
PharmiWeb.com
10 Dec 15 New Phase III Study of Nintedanib in People with Systemic Sclerosis and Lung Fibrosis Launched Pfizer ,
Published by
PharmiWeb.com
10 Dec 15 Pfizer Announces U.S. FDA Acceptance and Priority Review of Supplemental New Drug Application for XALKORI® (crizotinib) for the Treatment of Patients with ROS1-Positive Metastatic Non-Small Cell Lung Cancer Pfizer ,
Published by
PharmiWeb.com
10 Dec 15 Pfizer Awards More Than $4 Million in Grants to Further Clinical Research in Advanced Breast Cancer for 2015 Pfizer ,
Published by
PharmiWeb.com
10 Dec 15 Sunesis Pharmaceuticals Announces Submission of a Marketing Authorization Application for Vosaroxin for the Treatment of Acute Myeloid Leukemia in Europe Sunesis Pharmaceuticals ,
Published by
PharmiWeb.com
10 Dec 15 Sunesis Pharmaceuticals Announces Presentation of Positive Results From MD Anderson Sponsored Trial in AML at ASH Annual Meeting Sunesis Pharmaceuticals ,
Published by
PharmiWeb.com
10 Dec 15 Lymphoseek® Technically Successful in Evaluation of Sentinel Lymph Node Biopsy in Patients Undergoing Neoadjuvant Chemotherapy Navidea Biopharmaceuticals, Inc.,
Published by
Business Wire
10 Dec 15 Alexion Highlights Innovative Rare Disease Portfolio at Investor Day Meeting Alexion Pharmaceuticals, Inc.,
Published by
Business Wire
10 Dec 15 Lantheus Holdings Announces Appointment of Jack Crowley as Interim Chief Financial Officer Lantheus Holdings, Inc.,
Published by
Business Wire
10 Dec 15 Sunesis Pharmaceuticals Announces Presentation of Results From Washington University Sponsored Phase 1/2 Trial of Vosaroxin in MDS and VALOR Analysis of Baseline Safety Predictors at ASH Annual Meeting Sunesis Pharmaceuticals ,
Published by
PharmiWeb.com
10 Dec 15 FDA Approves Kanumaâ„¢ (sebelipase alfa) for the Treatment of Patients with Lysosomal Acid Lipase Deficiency (LAL-D) Alexion Pharmaceuticals,
Published by
PharmiWeb.com
10 Dec 15 Immune Design Highlights G100 Preclinical Data Demonstrating Direct and Abscopal Tumor Regression, Long-Term Response and Synergy With Checkpoint Blockade Read more: http://www.nasdaq.com/press-release/immune-design-highlights-g100-preclinical-data-demonstrating-direct-and-abscopal-tumor-regression-20151207-00967#ixzz3txR3m9v3 Immune Design ,
Published by
PharmiWeb.com
10 Dec 15 Teva Pharmaceuticals and Eagle Pharmaceuticals Announce FDA Approval of BENDEKAâ„¢ (bendamustine hydrochloride) Injection Teva Pharmaceuticals ,
Published by
PharmiWeb.com
10 Dec 15 Data from the International Paroxysmal Nocturnal Hemoglobinuria (PNH) Registry Presented at ASH Annual Meeting Underscore Devastating Nature of PNH and Benefits of Soliris® (eculizumab) Treatment Alexion Pharmaceuticals,
Published by
PharmiWeb.com
10 Dec 15 Acerta Pharma Announces Study Published in New England Journal of Medicine Demonstrates Acalabrutinib (ACP-196) Shows Marked Activity in Relapsed Chronic Lymphocytic Leukemia Acerta Pharma ,
Published by
PharmiWeb.com
10 Dec 15 Stemline Therapeutics Announces Five Presentations, Including SL-401 Clinical Update From Ongoing Pivotal BPDCN Trial, at the Upcoming American Society of Hematology (ASH) Annual Meeting Stemline Therapeutics ,
Published by
PharmiWeb.com
10 Dec 15 Stemline Therapeutics Presents Clinical Update From Ongoing SL-401 Pivotal BPDCN Trial at the American Society of Hematology (ASH) Annual Meeting Stemline Therapeutics ,
Published by
PharmiWeb.com
10 Dec 15 Creabilis completes EU FP7 project and selects two novel drug candidates for further development in atopic dermatitis and psoriasis Creabilis ,
Published by
PharmiWeb.com
10 Dec 15 Burzynski Research Institute, Inc. Announces Favorable Objective Response Rates and Overall Survival in Adults with Anaplastic Astrocytoma Following Antineoplastons A-10 and AS2-1 Burzynski Research Institute,
Published by
PharmiWeb.com
10 Dec 15 BeiGene Presents Clinical Data for BTK Inhibitor BGB-3111 at 57th ASH Annual Meeting BeiGene ,
Published by
PharmiWeb.com
10 Dec 15 Pfizer Receives U.S. FDA Approval of New QuilliChew ERâ„¢ (methylphenidate hydrochloride) extended-release chewable tablets CII Pfizer ,
Published by
PharmiWeb.com
10 Dec 15 Kite Pharma Announces Proposed Public Offering of Common Stock Kite Pharma ,
Published by
PharmiWeb.com
10 Dec 15 Kite Pharma Announces Pricing of Public Offering of Common Stock Kite Pharma ,
Published by
PharmiWeb.com
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.